Pinoresinol

Chemical Class	Furofuran lignan (phytoestrogen precursor)
Molecular Formula / CAS	C₂₀H₂₂O₆ · CAS 487-36-5
Primary Botanical Source(s)	Sesame seed (Sesamum indicum), olive oil (Olea europaea), flaxseed, Forsythia suspensa, Eucommia ulmoides
Plant Part	Seed (sesame, flax); fruit oil (olive); bark/fruit (Forsythia, Eucommia)
Typical Content	A minor lignan in sesame seed lignan profiles, alongside lariciresinol; trace-to-minor constituent of extra virgin olive oil phenolics
Solubility / Format	Present within whole-seed matrices and unrefined oils; not marketed as an isolated extract
Sourcing Status	Product-pending — genuine but non-standardised constituent of existing flax, sesame, and olive material
Buy from Herbuno	Availability on request — contact Herbuno for a formulation quote

Name origin: Pinoresinol was first characterised from pine resin (genus Pinus), giving the compound its name, though it has since been found distributed far more broadly across the plant kingdom than its namesake genus. Traditional use: As with matairesinol, pinoresinol was never used historically as an isolated preparation; its carrier plants each have independent traditional-medicine histories — sesame in Ayurvedic and East Asian formulations, olive across Mediterranean food and topical use, and Eucommia ulmoides bark in Traditional Chinese Medicine for joint and bone support, where pinoresinol glucosides are considered a partial marker of quality. Research trajectory: Early lignan research grouped pinoresinol with secoisolariciresinol and matairesinol as an enterolignan precursor, but more recent comparative work has identified pinoresinol specifically as exhibiting the strongest direct anti-inflammatory activity of the major dietary lignans in intestinal cell models, shifting research attention toward pinoresinol’s own bioactivity rather than solely its downstream metabolites. Commercial source: No supplier markets a pinoresinol-standardised botanical extract; it occurs as a natural, non-standardised constituent within sesame seed, flaxseed, and unrefined olive oil material.

---

Evidence for Pinoresinol Applications

Pinoresinol is one of the four principal dietary furofuran and dibenzylbutyrolactone lignans (alongside lariciresinol, secoisolariciresinol and matairesinol) that together account for the majority of lignan intake in a typical diet, with pinoresinol and lariciresinol contributing roughly three-quarters of total dietary lignan exposure by weight in most food-composition surveys. Like the other three, a portion of ingested pinoresinol undergoes bacterial conversion in the colon toward the enterolignans enterodiol and enterolactone, though pinoresinol also exerts activity independent of this conversion pathway. Claim strength: Moderate.

In comparative screening across the major dietary lignans, pinoresinol has been identified as exhibiting the strongest anti-inflammatory activity in human intestinal Caco-2 cell models, acting via suppression of NF-κB signalling in a manner researchers have linked to its furofuran ring structure and its pattern of intestinal metabolism. This positions pinoresinol as a candidate for gut-barrier and mucosal-health applications distinct from the phytoestrogen framing typically applied to lignans as a class. Claim strength: Moderate.

A 2025 human buccal cell study extended this gut-barrier finding to the oral epithelium, reporting that pinoresinol treatment reduced epithelial permeability and increased transepithelial electrical resistance in TR146 cell monolayers, alongside upregulated expression of the tight-junction proteins occludin, MarvelD3, claudin-1 and claudin-3 at both mRNA and protein levels (et al. 2025). This is an in-vitro cell-monolayer finding and has not been tested in human oral tissue or clinical settings. Claim strength: Emerging.

Pinoresinol diglucoside, the glycosylated form of pinoresinol characteristic of Eucommia ulmoides bark, has shown neuroprotective activity in a rodent ischemia-reperfusion model: intravenous administration reduced neurological deficit scores, infarct volume and pro-inflammatory cytokine levels (TNF-α, IL-1β, IL-6) while increasing antioxidant enzyme activity, through combined NF-κB suppression and Nrf2/HO-1 pathway activation (Zhang et al. 2021). Note this specific result concerns the diglucoside conjugate rather than free pinoresinol, and the animal-model dosing route (intravenous) does not translate directly to oral supplementation. Claim strength: Emerging.

Isolated pinoresinol has also demonstrated pro-apoptotic activity in glioblastoma cell lines resistant to TRAIL-induced apoptosis, where it accelerated degradation of the anti-apoptotic protein cFLIP-L and sensitised resistant cells to TRAIL-mediated cell death without affecting normal astrocytes in the same assay (Bax et al.). This selective sensitising effect is an early mechanistic finding from a single research group and would need independent replication before any therapeutic relevance could be assessed. Claim strength: Emerging.

---

Dosage & Formulator Specification

No standardised pinoresinol extract exists in commercial supply. Dietary intake estimates for combined pinoresinol and lariciresinol in a typical Western diet fall in the low single-digit milligram range per day, with sesame seed and sesame oil representing concentrated but still non-isolated dietary sources; no established supplemental dosing range exists for the isolated compound.

Analytical quantification of pinoresinol requires LC-MS/MS methods capable of distinguishing it from the closely related lariciresinol and matairesinol, since all three co-occur in the same seed and bark matrices and share near-identical retention behaviour on standard reverse-phase HPLC without mass-spectrometric confirmation. Suppliers reporting only an aggregate lignan percentage cannot substantiate a pinoresinol-specific claim.

In practice, formulation work involving pinoresinol means sourcing sesame seed extract, flaxseed extract, or unrefined (not RBD-processed) olive oil, each of which carries pinoresinol as a minor component within a broader phenolic or lignan matrix rather than as an isolated ingredient. Refined, bleached and deodorised olive oil retains negligible pinoresinol content compared with unrefined or extra-virgin grades.

Regulatory positioning follows standard food-ingredient pathways for sesame, flax and olive material, all of which have long-established food-use histories; no pinoresinol-specific monograph or intake limit exists in major pharmacopoeial references. Formulators should avoid implying gut-barrier or neuroprotective claims tied specifically to pinoresinol content unless the ingredient carries verified analytical data supporting the claimed concentration.

---

Frequently Asked Questions — Pinoresinol

Related compounds: Matairesinol, Oleuropein Aglycone